ARTICLE | Clinical News
Amantadine: Phase III data
September 26, 2016 7:00 AM UTC
Top-line data from the double-blind, international Phase III EASE LID 3 trial in 77 PD patients with levodopa-induced dyskinesia showed that 340 mg oral ADS-5102 once nightly at bedtime met the primar...